F-box proteins and cancer: An update from functional and regulatory mechanism to therapeutic clinical prospects

94Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are further classified into three sub-families: 1) F-box with leucine rich amino acid repeats (FBXL); 2) F-box with WD 40 amino acid repeats (FBXW); 3) F-box only with uncharacterized domains (FBXO). Here, we summarize the substrates of F-box proteins, discuss the important molecular mechanism and emerging role of F-box proteins especially from the perspective of cancer development and progression. These findings will shed new light on malignant tumor progression mechanisms, and suggest the potential role of F-box proteins as cancer biomarkers and therapeutic targets for future cancer treatment.

Cite

CITATION STYLE

APA

Tekcham, D. S., Chen, D., Liu, Y., Ling, T., Zhang, Y., Chen, H., … Liu, H. (2020). F-box proteins and cancer: An update from functional and regulatory mechanism to therapeutic clinical prospects. Theranostics, 10(9), 4150–4167. https://doi.org/10.7150/thno.42735

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free